Document Detail


Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins.
MedLine Citation:
PMID:  22800197     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Export pumps often limit the usefulness of anticancer drugs. Here we investigated the effect of cisplatin on the expression of ABC proteins in human colon cancer cells. Short-term incubation of Caco-2 and LS174T cells with cisplatin resulted in up-regulation of several ABC pumps, in particular MRP2 and BCRP. In partially cisplatin-resistant cells (LS174T/R) obtained by long-term exposure to cisplatin, MRP2 and BCRP up-regulation was more marked. This was further enhanced when these cells were cultured under maintained stimulation with cisplatin. The MRP2 promoter (MRP2pr) was cloned and partially deleted constructs linked to reporter genes were generated. Transfection of LS174T and LS174T/R cells with these constructs revealed the ability of cisplatin to activate MRP2pr. The intensity of this response was dependent on the conserved MRP2pr region. Basal MRP2pr activity was higher in LS174T/R cells, in which the expression of the transcription factors c/EBPβ, HNF1α, HNF3β and HNF4α, but not PXR, p53, c-Myc, AP1, YB-1, NRF2 and RARα was enhanced. Up-regulation was particularly high for FXR (200-fold) and SHP (50-fold). In LS174T/R cells, GW4064 induced the expression of FGF19, SHP, OSTα/β, but not MRP2 and BCRP, although the sensitivity of these cells to cisplatin was further reduced. In LS174T cells, GW4064-induced chemoresistance was seen only after being transfected with FXR+RXR, when BCRP, but not MRP2, was up-regulated. Protection of LS174T cells against cisplatin was mimicked by transfection with BCRP. In conclusion, in colon cancer cells, cisplatin treatment enhances chemoresistance through FXR-dependent and FXR-independent mechanisms, involving the expression of BCRP and MRP2, respectively.
Authors:
Elisa Herraez; Ester Gonzalez-Sanchez; Javier Vaquero; Marta R Romero; Maria A Serrano; Jose J G Marin; Oscar Briz
Related Documents :
11292377 - Developmental roles of the glypicans.
10048587 - Effect of insulin-like growth factor (igf)-i and des (1-3) igf-i on the level of igf bi...
20701957 - Growth-suppressing function of glypican-3 (gpc3) via insulin like growth factor ii (igf...
8636277 - Secretion of insulin-like growth factors and their binding proteins by human normal and...
25371367 - Stat3-efemp2a modulates the fibrillar matrix for cohesive movement of prechordal plate ...
11432917 - Ultrastructural localization of photosynthetic and photorespiratory enzymes in epiderma...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-7-16
Journal Detail:
Title:  Molecular pharmaceutics     Volume:  -     ISSN:  1543-8392     ISO Abbreviation:  -     Publication Date:  2012 Jul 
Date Detail:
Created Date:  2012-7-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101197791     Medline TA:  Mol Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  EPR/ENDOR, Mössbauer, and quantum-chemical investigations of diiron complexes mimicking the active ...
Next Document:  Screening-engineered Field-effect Solar Cells.